FDA Adverse Event Malfunction Summary report: N

ARCHITECT CA19-9XR

MDR report key: 23864048 · Received December 22, 2025

Report

Report Number
3002809144-2025-00404
Event Type
Malfunction
Date Received
December 22, 2025
Date of Event
December 17, 2025
Report Date
January 21, 2026
Manufacturer
ABBOTT GMBH
Product Code
NIG
UDI-DI
00380740137175
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A COMPLAINT INVESTIGATION WAS CONDUCTED FOR THE ARCHITECT CA19-9XR REAGENT, LOT 77713FP00. REVIEW OF TRACKING AND TRENDING BY LIST NUMBER AND BY COMPLAINT LOT DID NOT IDENTIFY ANY TRENDS. DEVICE HISTORY REVIEW DID NOT IDENTIFY ANY NONCONFORMANCES, POTENTIAL NONCONFORMANCES, OR DEVIATIONS ASSOCIATED WITH THE COMPLAINT LOT. THE OVERALL PERFORMANCE OF THE ARCHITECT CA19-9XR REAGENTS IN THE FIELD WAS REVIEWED USING DATA GATHERED FROM CUSTOMERS WORLDWIDE. REVIEW SHOWS THE MEDIAN PATIENT RESULT FOR THE LOT IS WITHIN THE ESTABLISHED LIMITS, INDICATING THE LOT IS PERFORMING AS EXPECTED. LABELING WAS REVIEWED AND ADEQUATELY ADDRESSES THE ISSUE. BASED ON THE INVESTIGATION, THERE IS NO SYSTEMIC ISSUE OR DEFICIENCY OF THE ARCHITECT CA19-9XR REAGENT, LOT 77713FP00.

Additional Manufacturer Narrative · 0

AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 2K91-39 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 2K91 - 39, WITH 510K/PMA/BLA NUMBER K052000.

Description of Event or Problem · 0

THE CUSTOMER REPORTED FALSELY ELEVATED ARCHITECT CA 19-9XR AND PROVIDED THE FOLLOWING DATA: ORIGINAL RESULT WAS >1200 ON LOT 77713FP00. PER THE CUSTOMER DISCREPANT RESULTS WERE NOT REPORTED OUT TO THE MEDICAL PROVIDER. THERE WAS NO REPORTED IMPACT TO PATIENT MANAGEMENT.

Description of Event or Problem · 0

THE CUSTOMER REPORTED FALSELY ELEVATED ARCHITECT CA 19-9XR AND PROVIDED THE FOLLOWING DATA: ORIGINAL RESULT WAS >1200 ON LOT 77713FP00. PER THE CUSTOMER DISCREPANT RESULTS WERE NOT REPORTED OUT TO THE MEDICAL PROVIDER. THERE WAS NO REPORTED IMPACT TO PATIENT MANAGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2445326 ARCHITECT CA19-9XR SYSTEM, TEST, CARBOHYDRATE AG (CA19-9), FOR MONIT AND MGMT OF PANCREATIC CANCER NIG ABBOTT GMBH 77713FP00 00380740137175

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown ARC I2K PROC MOD, 03M74-01, (B)(6)